CYCLOCORT DIN 02192276
Health Canada record
| Active ingredient(s) | AMCINONIDE 0.1 % |
|---|---|
| Dosage form | Lotion |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AC11 AMCINONIDE |
| Original market date | 12-Sep-1996 |
| Current status date | 14-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMCINONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02246714 | TARO-AMCINONIDE | TARO PHARMACEUTICALS INC | Cream | AMCINONIDE 0.1 % | Marketed |
| 02192268 | CYCLOCORT | GLAXOSMITHKLINE INC | Ointment | AMCINONIDE 0.1 % | Cancelled Post Market |
| 02192284 | CYCLOCORT | GLAXOSMITHKLINE INC | Cream | AMCINONIDE 0.1 % | Cancelled Post Market |
| 02247096 | RATIO-AMCINONIDE | TEVA CANADA LIMITED | Ointment | AMCINONIDE 0.1 % | Cancelled Post Market |
| 02247097 | RATIO-AMCINONIDE | TEVA CANADA LIMITED | Lotion | AMCINONIDE 0.1 % | Cancelled Post Market |
| 02247098 | RATIO-AMCINONIDE | TEVA CANADA LIMITED | Cream | AMCINONIDE 0.1 % | Cancelled Post Market |
| 02257416 | TARO-AMCINONIDE | TARO PHARMACEUTICALS INC | Ointment | AMCINONIDE 0.1 % | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11425 | 2010-05-27 | New Drug Submission (NDS) | Manufacturer name change |
International API supply for AMCINONIDE
4 active FDA Drug Master Files.
Request a quote for CYCLOCORT